SARS-COV-2 AND ARBOVIRUS INFECTIONS: PROTOCOL FOR A RAPID LIVING SYSTEMATIC REVIEW
DOI:
https://doi.org/10.1590/SciELOPreprints.346Keywords:
COVID-19, Arbovirus infection, Systematic ReviewResumo
Context and objective: While cases of COVID-19 disease increase daily worldwide, outbreaks of arboviral infections have affected health systems of countries in tropical regions. The outcomes for patients and health systems of a possible syndemic are not clarified yet. Thus, we aim to systematically review the literature searching for evidence that describes the clinical presentation, severity and prognostic of SARS-CoV-2 and Arboviral coinfection. Design and setting: Protocol for a rapid living systematic review, that will follow the Cochrane Handbook for Systematic Reviews recommendations. We will include prospective and retrospective cohort, case-control studies and case series of patients with confirmed diagnosis of SARS-CoV-2 and Arboviral infection. We will perform the search strategy with no language restrictions on Medline via PubMed, Embase via Elsevier, Cochrane Library - Cochrane Central Register of Controlled Trials (CENTRAL), Portal Regional BVS - LILACS, Scopus and WebOfScience to identify published, ongoing, and unpublished studies. The selection and extraction will be performed by two authors. We will perform the critical appraisal of included studies with the Newcastle-Ottawa Scale and the certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE).
Downloads
Métricas
Postado
Como Citar
Série
Copyright (c) 2020 Keilla Martins Milby, Alvaro Nagib Atallah, César Ramos Rocha-Filho, Ana Carolina Pereira Nunes Pinto, Aline Pereira da Rocha, Felipe Sebastião de Assis Reis, Nelson Carvas Junior, Vinicius Tassoni Civile, Rodolfo Rodrigo Pereira Santos, Laura Jantsch Ferla, Giulia Fernandes Moça Trevisani, Gabriel Sodré Ramalho, Virgínia Fernandes Moça Trevisani

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.